Changeflow GovPing Courts & Legal AG Wilson Leads 13 States Supporting Bill to Wi...
Routine Notice Added Consultation

AG Wilson Leads 13 States Supporting Bill to Withdraw Mifepristone from FDA Approval

Favicon for www.scag.gov AG: South Carolina News
Published
Detected
Email

Summary

Attorney General Alan Wilson of South Carolina announced he is leading 13 other state AGs in a letter supporting Senator Josh Hawley's 'Safeguarding Women from Chemical Abortion Act.' The proposed federal legislation would withdraw mifepristone from the FDA's approval list and create a private right of action allowing women harmed by mifepristone to file civil lawsuits.

Published by SC AG on scag.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

South Carolina Attorney General Alan Wilson announced he is leading a coalition of 13 state AGs in support of Senator Josh Hawley's 'Safeguarding Women from Chemical Abortion Act.' The proposed federal legislation would withdraw mifepristone from the FDA's approved drug list and establish a private right of action enabling women who experience harm from mifepristone to pursue civil litigation.

If enacted, this legislation would significantly impact pharmaceutical manufacturers producing mifepristone, healthcare providers prescribing or dispensing the drug, and women who have used or may use mifepristone. Affected parties should monitor this legislation's progress and assess potential legal and operational implications.

What to do next

  1. Monitor legislative progress of the Safeguarding Women from Chemical Abortion Act
  2. Review mifepristone-related compliance policies
  3. Consult legal counsel on potential civil liability exposure

Penalties

Proposed legislation would create civil cause of action allowing women harmed by mifepristone to seek damages in court

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

APR 09, 2026

Attorney General Alan Wilson leads pro-life effort to withdraw mifepristone from FDA approval list

(COLUMBIA, S.C.) – Attorney General Alan Wilson is leading 13 other states in a letter supporting Senator Josh Hawley’s “Safeguarding Women from Chemical Abortion Act.”

This legislation would withdraw mifepristone from the FDA’s approval list. If it becomes law, the act would also create a cause of action for any woman harmed by mifepristone to take civil action.

“As Attorney General, I have supported legislation in South Carolina to reclassify mifepristone and outlaw telehealth abortions,” Attorney General Wilson said. “I have protected life at every opportunity, fighting to defend the unborn in South Carolina courts and courts across the country. This is just another step to ensure we protect those who cannot protect themselves.”

The letter cites the widespread distribution of mifepristone, its current primary use for abortions, and the risks that it poses to the health, safety, and well-being of citizens in every state.

“As a father, the fight to defend life will always be a top priority,” Attorney General Wilson stated. “But it doesn’t stop there. We must protect the lives of the pre-born while also ensuring women who have been harmed can seek justice.”

In addition to South Carolina, attorneys general from the following states joined the letter to Senator Hawley: Alabama, Arkansas, Florida, Idaho, Kansas, Louisiana, Missouri, Montana, Nebraska, Ohio, Oklahoma, South Dakota, and Texas.

You can read the letter here.

Back to News

Media Contact

For media inquiries please contact Robert Kittle, [email protected] or 803-734-3670

Media Contact

Named provisions

Mifepristone FDA Withdrawal Civil Cause of Action

Get daily alerts for AG: South Carolina News

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from SC AG.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
SC AG
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Consultation
Change scope
Minor
Document ID
Safeguarding Women from Chemical Abortion Act

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
FDA drug approval Pharmaceutical manufacturing Prescription drug distribution
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Healthcare Product Safety

Get alerts for this source

We'll email you when AG: South Carolina News publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!